Ontology type: schema:ScholarlyArticle
1990-11
AUTHORSR. P. Castleberry, A. H. Ragab, C. P. Steuber, B. Kamen, S. Toledano, K. Starling, D. Norris, P. Burger, J. P. Krischer
ABSTRACTTo assess the response rates and toxicity of AZQ in children with recurrent brain and other malignant solid tumors, a phase II study was implemented by the Pediatric Oncology Group. Eligible patients received AZQ 18 mg/M2/week i.v. for 4 doses followed by a 2 week rest period. Each dose was given over four hours (1/3 over the initial 20 minutes). After the first year, the dosage was reduced to 13 mg/M2 due to myelotoxicity resulting in treatment delays. No objective responses were observed in 73 evaluable children with various non-central nervous system tumors. Of the 91 patients with brain tumors, there were 4 CR's and 2 PR's in patients with astrocytoma, ependymoma, glioblastoma multiforme, oligodendroglioma, brain stem glioma and intracranial yolk sac tumor (median duration, 10 months; range, 2-20+ months). Three of 4 CR's were achieved with a dosage of 18 mg/M2/week. An additional 13 children with brain tumors experienced stable or improved disease (duration, 2-36 + months; median 7.5 months). The principal toxicity was myelosuppression which was cumulative but there were also 3 allergic reactions to AZQ. We conclude that for selected brain tumors, the rates of objective response and stable disease plus the duration of responses support further assessment of AZQ in combination with other agents. Furthermore, the 18 mg/M2 dosage may provide better responses. More... »
PAGES401-406
http://scigraph.springernature.com/pub.10.1007/bf00198601
DOIhttp://dx.doi.org/10.1007/bf00198601
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1017171155
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/2084075
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Neurosciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adolescent",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aziridines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Benzoquinones",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Brain Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child, Preschool",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Administration Schedule",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Evaluation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drugs, Investigational",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Recurrence, Local",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasms",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "University of Alabama at Birmingham",
"id": "https://www.grid.ac/institutes/grid.265892.2",
"name": [
"The Departments of Pediatrics of the University of Alabama at Birmingham, USA"
],
"type": "Organization"
},
"familyName": "Castleberry",
"givenName": "R. P.",
"id": "sg:person.0626116531.27",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626116531.27"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Emory University",
"id": "https://www.grid.ac/institutes/grid.189967.8",
"name": [
"Emory University, USA"
],
"type": "Organization"
},
"familyName": "Ragab",
"givenName": "A. H.",
"id": "sg:person.010643352004.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643352004.84"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Baylor University",
"id": "https://www.grid.ac/institutes/grid.252890.4",
"name": [
"Baylor University, USA"
],
"type": "Organization"
},
"familyName": "Steuber",
"givenName": "C. P.",
"type": "Person"
},
{
"affiliation": {
"alternateName": "The University of Texas Southwestern Medical Center",
"id": "https://www.grid.ac/institutes/grid.267313.2",
"name": [
"University of Texas Southwestern Medical School, USA"
],
"type": "Organization"
},
"familyName": "Kamen",
"givenName": "B.",
"id": "sg:person.0616713135.35",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616713135.35"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Miami",
"id": "https://www.grid.ac/institutes/grid.26790.3a",
"name": [
"University of Miami, USA"
],
"type": "Organization"
},
"familyName": "Toledano",
"givenName": "S.",
"id": "sg:person.01242012473.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242012473.51"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "West Virginia University",
"id": "https://www.grid.ac/institutes/grid.268154.c",
"name": [
"West Virginia University, USA"
],
"type": "Organization"
},
"familyName": "Starling",
"givenName": "K.",
"id": "sg:person.065570553.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.065570553.31"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"The Cleveland Clinics, USA"
],
"type": "Organization"
},
"familyName": "Norris",
"givenName": "D.",
"id": "sg:person.01141744115.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141744115.25"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Duke University Hospital",
"id": "https://www.grid.ac/institutes/grid.189509.c",
"name": [
"Duke University Medical Center, USA"
],
"type": "Organization"
},
"familyName": "Burger",
"givenName": "P.",
"id": "sg:person.0653131115.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653131115.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Florida",
"id": "https://www.grid.ac/institutes/grid.15276.37",
"name": [
"The University of Florida and member institutions of The Pediatric Oncology Group, St. Louis, USA"
],
"type": "Organization"
},
"familyName": "Krischer",
"givenName": "J. P.",
"id": "sg:person.015434510637.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015434510637.88"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/bf00165153",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002279955",
"https://doi.org/10.1007/bf00165153"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00165185",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002576749",
"https://doi.org/10.1007/bf00165185"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00180194",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009528930",
"https://doi.org/10.1007/bf00180194"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0277-5379(84)90193-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012921883"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/1097-0142(19850915)56:6<1311::aid-cncr2820560615>3.0.co;2-v",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031779669"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00148387",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041519111",
"https://doi.org/10.1007/bf00148387"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00148387",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041519111",
"https://doi.org/10.1007/bf00148387"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00153636",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045673869",
"https://doi.org/10.1007/bf00153636"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00153636",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045673869",
"https://doi.org/10.1007/bf00153636"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1987.5.3.464",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1079514700"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1079995803",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1080114927",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1081779436",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1081874945",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1081908006",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1082281986",
"type": "CreativeWork"
}
],
"datePublished": "1990-11",
"datePublishedReg": "1990-11-01",
"description": "To assess the response rates and toxicity of AZQ in children with recurrent brain and other malignant solid tumors, a phase II study was implemented by the Pediatric Oncology Group. Eligible patients received AZQ 18 mg/M2/week i.v. for 4 doses followed by a 2 week rest period. Each dose was given over four hours (1/3 over the initial 20 minutes). After the first year, the dosage was reduced to 13 mg/M2 due to myelotoxicity resulting in treatment delays. No objective responses were observed in 73 evaluable children with various non-central nervous system tumors. Of the 91 patients with brain tumors, there were 4 CR's and 2 PR's in patients with astrocytoma, ependymoma, glioblastoma multiforme, oligodendroglioma, brain stem glioma and intracranial yolk sac tumor (median duration, 10 months; range, 2-20+ months). Three of 4 CR's were achieved with a dosage of 18 mg/M2/week. An additional 13 children with brain tumors experienced stable or improved disease (duration, 2-36 + months; median 7.5 months). The principal toxicity was myelosuppression which was cumulative but there were also 3 allergic reactions to AZQ. We conclude that for selected brain tumors, the rates of objective response and stable disease plus the duration of responses support further assessment of AZQ in combination with other agents. Furthermore, the 18 mg/M2 dosage may provide better responses.",
"genre": "research_article",
"id": "sg:pub.10.1007/bf00198601",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isFundedItemOf": [
{
"id": "sg:grant.2693162",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2693295",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2693270",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1094201",
"issn": [
"0167-6997",
"1573-0646"
],
"name": "Investigational New Drugs",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "8"
}
],
"name": "Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors",
"pagination": "401-406",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"51cf607a92c430b57f26f5fc6a457aaa25027bd012fb2000825f0f7c54c6a306"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"2084075"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8309330"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/bf00198601"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1017171155"
]
}
],
"sameAs": [
"https://doi.org/10.1007/bf00198601",
"https://app.dimensions.ai/details/publication/pub.1017171155"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T13:49",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130794_00000001.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007/BF00198601"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00198601'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00198601'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00198601'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00198601'
This table displays all metadata directly associated to this object as RDF triples.
250 TRIPLES
21 PREDICATES
57 URIs
35 LITERALS
23 BLANK NODES